Organism name | Feijoa sellowiana |
---|---|
Genus | Feijoa |
Family | Myrtaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Acca sellowiana |
---|---|
Linked NCBI taxonomy ID | 260130 |
Linked level | species |
Family in NCBI taxonomy | Myrtaceae |
---|---|
ID | 3931 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00000919
![]() |
beta-Carotene
|
CHEMBL1293
CHEMBL1966639 |
D019207
|
7 / 12 / 11 | 104 / 19 | No. 26 | No. 59 |
![]() |
C00003674
![]() |
Stigmasterol
/ beta-Stigmasterol |
CHEMBL66943
CHEMBL186373 CHEMBL400247 CHEMBL1568947 |
D013265
|
5 / 0 / 0 | 1 / 0 | No. 53 | No. 11 |
![]() |
C00001040
![]() |
Flavone
|
CHEMBL275638
|
C043562
|
58 / 40 / 58 | 14 / 0 | No. 76 | No. 15 |
![]() |
C00002910
![]() |
Casuarinin
|
CHEMBL79244
CHEMBL507387 |
11 / 2 / 2 | No. 226 | No. 81 |
![]() |
||
C00002938
![]() |
Tellimagrandin I
|
CHEMBL450376
|
C087926
|
7 / 0 | No. 302 | No. 81 |
![]() |
|
C00007366
![]() |
alpha-Tocopherol
|
CHEMBL47
CHEMBL49563 CHEMBL442800 |
D024502
|
99 / 57 / 52 | 54 / 55 | No. 1290 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P33765 | Adenosine receptor A3 | Adenosine receptor | C00001040 C00007366 | 0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00001040 C00007366 | 0 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000919 C00007366 | 1 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00001040 C00007366 | 1 / 1 |
P04150 | Glucocorticoid receptor | NR3C1 | C00001040 C00007366 | 0 / 1 |
O75496 | Geminin | Unclassified protein | C00000919 C00001040 | 0 / 0 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00001040 C00003674 | 0 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00001040 C00007366 | 1 / 8 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000919 C00007366 | 0 / 0 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00001040 C00007366 | 1 / 1 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000919 C00007366 | 0 / 1 |
P00918 | Carbonic anhydrase 2 | Lyase | C00001040 C00007366 | 1 / 2 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00001040 C00007366 | 3 / 1 |
P02545 | Prelamin-A/C | Unclassified protein | C00000919 C00007366 | 11 / 10 |
P17252 | Protein kinase C alpha type | Alpha | C00002910 C00007366 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00007366 | 4 / 3 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00007366 | 0 / 0 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00001040 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00007366 | 2 / 2 |
P62158 | Calmodulin | Unclassified protein | C00001040 | 1 / 0 |
O95271 | Tankyrase-1 | Enzyme | C00001040 | 0 / 0 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00007366 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00007366 | 0 / 0 |
P06746 | DNA polymerase beta | Enzyme | C00003674 | 0 / 0 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00001040 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00007366 | 0 / 0 |
P78527 | DNA-dependent protein kinase catalytic subunit | Atypical serine/threonine protein kinase PIKK subfamily | C00001040 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00007366 | 1 / 0 |
P25021 | Histamine H2 receptor | Histamine receptor | C00007366 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00007366 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00007366 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00007366 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00007366 | 0 / 0 |
P08246 | Neutrophil elastase | S1A | C00007366 | 2 / 1 |
P34969 | 5-hydroxytryptamine receptor 7 | Serotonin receptor | C00003674 | 0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00001040 | 1 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00007366 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00007366 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00007366 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00007366 | 0 / 1 |
P16662 | UDP-glucuronosyltransferase 2B7 | Enzyme | C00007366 | 0 / 0 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00007366 | 2 / 2 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00007366 | 0 / 3 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00007366 | 2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00007366 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00007366 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00007366 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00007366 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00007366 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00007366 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00007366 | 1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00007366 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00007366 | 1 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00000919 | 0 / 0 |
P28845 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | Enzyme | C00001040 | 1 / 1 |
O43570 | Carbonic anhydrase 12 | Lyase | C00001040 | 1 / 2 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00007366 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00000919 | 0 / 0 |
P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | C00001040 | 0 / 0 |
P51151 | Ras-related protein Rab-9A | Unclassified protein | C00001040 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00007366 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00007366 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00007366 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00007366 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00007366 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00007366 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00007366 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00007366 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00007366 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00007366 | 0 / 0 |
P10145 | Interleukin-8 | Secreted protein | C00001040 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00007366 | 1 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | C00001040 | 0 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00007366 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00007366 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00007366 | 1 / 0 |
P09874 | Poly [ADP-ribose] polymerase 1 | Enzyme | C00001040 | 0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00001040 | 0 / 0 |
Q12791 | Calcium-activated potassium channel subunit alpha-1 | KCNM, KCa1.x | C00001040 | 1 / 1 |
P03956 | Interstitial collagenase | M10A | C00007366 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00007366 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00001040 | 0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00007366 | 0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00007366 | 0 / 0 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00007366 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00007366 | 0 / 0 |
P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00001040 | 2 / 2 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00007366 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00007366 | 2 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00007366 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00007366 | 1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00007366 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00007366 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00007366 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00007366 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00007366 | 1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00007366 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00007366 | 2 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00007366 | 0 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00001040 | 0 / 1 |
Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00001040 | 2 / 0 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00001040 | 2 / 2 |
O15118 | Niemann-Pick C1 protein | Unclassified protein | C00001040 | 1 / 1 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00001040 | 0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00001040 | 0 / 0 |
Q9H2K2 | Tankyrase-2 | Enzyme | C00001040 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00007366 | 0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00001040 | 4 / 1 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00001040 | 7 / 37 |
P09884 | DNA polymerase alpha catalytic subunit | Transferase | C00003674 | 0 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00007366 | 1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00007366 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00007366 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00007366 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00007366 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00007366 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00007366 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00007366 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00007366 | 1 / 1 |
P37059 | Estradiol 17-beta-dehydrogenase 2 | Enzyme | C00001040 | 0 / 0 |
P14061 | Estradiol 17-beta-dehydrogenase 1 | Enzyme | C00001040 | 0 / 0 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00007366 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00007366 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00007366 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00001040 | 0 / 0 |
P10275 | Androgen receptor | NR3C4 | C00001040 | 3 / 4 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00007366 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00007366 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00007366 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00007366 | 0 / 0 |
P15144 | Aminopeptidase N | M1 | C00001040 | 0 / 1 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00007366 | 1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | C00007366 | 0 / 1 |
P35869 | Aryl hydrocarbon receptor | Transcription Factor | C00001040 | 0 / 0 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00007366 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00007366 | 0 / 0 |
O00255 | Menin | Unclassified protein | C00007366 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00007366 | 1 / 2 |
Q05513 | Protein kinase C zeta type | Iota | C00002910 | 0 / 0 |
Q04759 | Protein kinase C theta type | Delta | C00002910 | 0 / 1 |
Q02156 | Protein kinase C epsilon type | Eta | C00002910 | 0 / 0 |
O94806 | Serine/threonine-protein kinase D3 | Pkd | C00002910 | 0 / 0 |
Q05655 | Protein kinase C delta type | Delta | C00002910 | 0 / 0 |
P05129 | Protein kinase C gamma type | Alpha | C00002910 | 1 / 1 |
P05771 | Protein kinase C beta type | Alpha | C00002910 | 0 / 0 |
P24723 | Protein kinase C eta type | Eta | C00002910 | 1 / 0 |
P41743 | Protein kinase C iota type | Iota | C00002910 | 0 / 0 |
Q15139 | Serine/threonine-protein kinase D1 | Pkd | C00002910 | 0 / 0 |
Q9UN88 | Gamma-aminobutyric acid receptor subunit theta | GABA-A theta | C00001040 | 0 / 0 |
P28472 | Gamma-aminobutyric acid receptor subunit beta-3 | GABA-A beta | C00001040 | 1 / 0 |
P14867 | Gamma-aminobutyric acid receptor subunit alpha-1 | GABA-A alpha | C00001040 | 1 / 1 |
P48169 | Gamma-aminobutyric acid receptor subunit alpha-4 | GABA-A alpha | C00001040 | 0 / 0 |
O14764 | Gamma-aminobutyric acid receptor subunit delta | GABA-A delta | C00001040 | 1 / 1 |
P31644 | Gamma-aminobutyric acid receptor subunit alpha-5 | GABA-A alpha | C00001040 | 0 / 0 |
Q99928 | Gamma-aminobutyric acid receptor subunit gamma-3 | GABA-A gamma | C00001040 | 0 / 0 |
P78334 | Gamma-aminobutyric acid receptor subunit epsilon | GABA-A epsilon | C00001040 | 0 / 0 |
Q8N1C3 | Gamma-aminobutyric acid receptor subunit gamma-1 | GABA-A gamma | C00001040 | 0 / 0 |
P34903 | Gamma-aminobutyric acid receptor subunit alpha-3 | GABA-A alpha | C00001040 | 0 / 0 |
O00591 | Gamma-aminobutyric acid receptor subunit pi | GABA-A pi | C00001040 | 0 / 0 |
P47870 | Gamma-aminobutyric acid receptor subunit beta-2 | GABA-A beta | C00001040 | 0 / 0 |
P18507 | Gamma-aminobutyric acid receptor subunit gamma-2 | GABA-A gamma | C00001040 | 4 / 2 |
P18505 | Gamma-aminobutyric acid receptor subunit beta-1 | GABA-A beta | C00001040 | 0 / 0 |
Q16445 | Gamma-aminobutyric acid receptor subunit alpha-6 | GABA-A alpha | C00001040 | 0 / 0 |
P47869 | Gamma-aminobutyric acid receptor subunit alpha-2 | GABA-A alpha | C00001040 | 1 / 0 |
Q02880 | DNA topoisomerase 2-beta | Isomerase | C00003674 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00000919
C00001040
C00007366
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00000919
C00007366
|
6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00000919
C00007366
|
6256 | RXRA, NR2B1 | retinoid X receptor, alpha |
C00000919
C00007366
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00000919
C00007366
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00000919
C00007366
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00000919
C00007366
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00000919
C00007366
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00000919
C00001040
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00000919
C00001040
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00000919
C00001040
|
23621 | BACE1, ASP2, BACE, HSPC104 | beta-site APP-cleaving enzyme 1 (EC:3.4.23.46) |
C00007366
|
2103 | ESRRB, DFNB35, ERR2, ERRb, ESRL2, NR3B2 | estrogen-related receptor beta |
C00001040
|
5444 | PON1, ESA, MVCD5, PON | paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) |
C00001040
|
43 | ACHE, ACEE, ARACHE, N-ACHE, YT | acetylcholinesterase (EC:3.1.1.7) |
C00002938
|
2623 | GATA1, ERYF1, GATA-1, GF-1, GF1, NF-E1, NFE1, XLANP, XLTDA, XLTT | GATA binding protein 1 (globin transcription factor 1) |
C00002938
|
2624 | GATA2, DCML, MONOMAC, NFE1B | GATA binding protein 2 |
C00002938
|
2993 | GYPA, CD235a, GPA, GPErik, GPSAT, HGpMiV, HGpMiXI, HGpSta(C), MN, MNS, PAS-2 | glycophorin A (MNS blood group) |
C00002938
|
3145 | HMBS, PBG-D, PBGD, PORC, UPS | hydroxymethylbilane synthase (EC:2.5.1.61) |
C00002938
|
3690 | ITGB3, BDPLT16, BDPLT2, CD61, GP3A, GPIIIa, GT | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
C00002938
|
4778 | NFE2, NF-E2, p45 | nuclear factor, erythroid 2 |
C00002938
|
10599 | SLCO1B1, HBLRR, LST-1, LST1, OATP-C, OATP1B1, OATP2, OATPC, SLC21A6 | solute carrier organic anion transporter family, member 1B1 |
C00003674
|
124 | ADH1A, ADH1 | alcohol dehydrogenase 1A (class I), alpha polypeptide (EC:1.1.1.1) |
C00000919
|
128 | ADH5, ADH-3, ADHX, FALDH, FDH, GSH-FDH, GSNOR | alcohol dehydrogenase 5 (class III), chi polypeptide (EC:1.1.1.1 1.1.1.284) |
C00000919
|
221 | ALDH3B1, ALDH4, ALDH7 | aldehyde dehydrogenase 3 family, member B1 (EC:1.2.1.5) |
C00000919
|
8659 | ALDH4A1, ALDH4, P5CD, P5CDh | aldehyde dehydrogenase 4 family, member A1 (EC:1.2.1.88) |
C00000919
|
287 | ANK2, ANK-2, LQT4, brank-2 | ankyrin 2, neuronal |
C00000919
|
288 | ANK3, ANKYRIN-G, MRT37 | ankyrin 3, node of Ranvier (ankyrin G) |
C00000919
|
427 | ASAH1, AC, ACDase, ASAH, PHP, PHP32, SMAPME | N-acylsphingosine amidohydrolase (acid ceramidase) 1 (EC:3.5.1.23) |
C00000919
|
51665 | ASB1, ASB-1 | ankyrin repeat and SOCS box containing 1 |
C00000919
|
140462 | ASB9 | ankyrin repeat and SOCS box containing 9 |
C00000919
|
9531 | BAG3, BAG-3, BIS, CAIR-1, MFM6 | BCL2-associated athanogene 3 |
C00000919
|
9530 | BAG4, BAG-4, SODD | BCL2-associated athanogene 4 |
C00000919
|
9529 | BAG5, BAG-5 | BCL2-associated athanogene 5 |
C00000919
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00001040
|
53630 | BCMO1, BCDO, BCDO1, BCMO, BCO, BCO1 | beta-carotene 15,15'-monooxygenase 1 (EC:1.14.99.36) |
C00000919
|
999 | CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO | cadherin 1, type 1, E-cadherin (epithelial) |
C00000919
|
8837 | CFLAR, CASH, CASP8AP1, CLARP, Casper, FLAME, FLAME-1, FLAME1, FLIP, I-FLICE, MRIT, c-FLIP, c-FLIPL, c-FLIPR, c-FLIPS | CASP8 and FADD-like apoptosis regulator |
C00000919
|
9071 | CLDN10, CPETRL3, OSP-L | claudin 10 |
C00000919
|
51208 | CLDN18, SFTA5, SFTPJ | claudin 18 |
C00000919
|
1277 | COL1A1, OI4 | collagen, type I, alpha 1 |
C00000919
|
1282 | COL4A1, HANAC, ICH, POREN1, arresten | collagen, type IV, alpha 1 |
C00000919
|
1284 | COL4A2, ICH, POREN2 | collagen, type IV, alpha 2 |
C00000919
|
8738 | CRADD, MRT34, RAIDD | CASP2 and RIPK1 domain containing adaptor with death domain |
C00000919
|
1508 | CTSB, APPS, CPSB | cathepsin B (EC:3.4.22.1) |
C00000919
|
6387 | CXCL12, IRH, PBSF, SCYB12, SDF1, TLSF, TPAR1, SDF1A, SDF1B | chemokine (C-X-C motif) ligand 12 |
C00000919
|
6372 | CXCL6, CKA-3, GCP-2, GCP2, SCYB6 | chemokine (C-X-C motif) ligand 6 |
C00000919
|
4283 | CXCL9, CMK, Humig, MIG, SCYB9, crg-10 | chemokine (C-X-C motif) ligand 9 |
C00000919
|
7852 | CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM | chemokine (C-X-C motif) receptor 4 |
C00000919
|
1592 | CYP26A1, CP26, CYP26, P450RAI, P450RAI1 | cytochrome P450, family 26, subfamily A, polypeptide 1 (EC:1.14.-.-) |
C00000919
|
64816 | CYP3A43 | cytochrome P450, family 3, subfamily A, polypeptide 43 (EC:1.14.14.1) |
C00000919
|
1746 | DLX2, TES-1, TES1 | distal-less homeobox 2 |
C00000919
|
1748 | DLX4, BP1, DLX7, DLX8, DLX9 | distal-less homeobox 4 |
C00000919
|
2068 | ERCC2, COFS2, EM9, TTD, XPD | excision repair cross-complementing rodent repair deficiency, complementation group 2 (EC:3.6.4.12) |
C00000919
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00000919
|
23017 | FAIM2, LFG, LFG2, NGP35, NMP35, TMBIM2 | Fas apoptotic inhibitory molecule 2 |
C00000919
|
355 | FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6 | Fas cell surface death receptor |
C00000919
|
3169 | FOXA1, HNF3A, TCF3A | forkhead box A1 |
C00000919
|
2627 | GATA6 | GATA binding protein 6 |
C00000919
|
2633 | GBP1 | guanylate binding protein 1, interferon-inducible |
C00000919
|
81025 | GJA9, CX58, CX59, GJA10 | gap junction protein, alpha 9, 59kDa |
C00000919
|
373156 | GSTK1, GST, GST_13-13, GST13, GST13-13, GSTK1-1, hGSTK1 | glutathione S-transferase kappa 1 (EC:2.5.1.18) |
C00000919
|
2946 | GSTM2, GST4, GSTM, GSTM2-2, GTHMUS | glutathione S-transferase mu 2 (muscle) (EC:2.5.1.18) |
C00000919
|
2948 | GSTM4, GSTM4-4, GTM4 | glutathione S-transferase mu 4 (EC:2.5.1.18) |
C00000919
|
2949 | GSTM5, GSTM5-5, GTM5 | glutathione S-transferase mu 5 (EC:2.5.1.18) |
C00000919
|
2954 | GSTZ1, GSTZ1-1, MAAI, MAI | glutathione S-transferase zeta 1 (EC:2.5.1.18 5.2.1.2) |
C00000919
|
3204 | HOXA7, ANTP, HOX1, HOX1.1, HOX1A | homeobox A7 |
C00000919
|
3216 | HOXB6, HOX2, HOX2B, HU-2, Hox-2.2 | homeobox B6 |
C00000919
|
3226 | HOXC10, HOX3I | homeobox C10 |
C00000919
|
3448 | IFNA14, IFN-alphaH, LEIF2H | interferon, alpha 14 |
C00000919
|
3449 | IFNA16, IFN-alphaO | interferon, alpha 16 |
C00000919
|
3451 | IFNA17, IFN-alphaI, IFNA, INFA, LEIF2C1 | interferon, alpha 17 |
C00000919
|
3442 | IFNA5, IFN-alpha-5, IFN-alphaG, INA5, INFA5, leIF_G | interferon, alpha 5 |
C00000919
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00000919
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00001040
|
3394 | IRF8, H-ICSBP, ICSBP, ICSBP1, IRF-8 | interferon regulatory factor 8 |
C00000919
|
50805 | IRX4, IRXA3 | iroquois homeobox 4 |
C00000919
|
3688 | ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
C00000919
|
3691 | ITGB4, CD104 | integrin, beta 4 |
C00000919
|
3713 | IVL | involucrin |
C00000919
|
3875 | KRT18, CYK18, K18 | keratin 18 |
C00000919
|
3880 | KRT19, CK19, K19, K1CS | keratin 19 |
C00000919
|
3849 | KRT2, CK-2e, K2e, KRT2A, KRT2E, KRTE | keratin 2 |
C00000919
|
3855 | KRT7, CK7, K2C7, K7, SCL | keratin 7 |
C00000919
|
3856 | KRT8, CARD2, CK-8, CK8, CYK8, K2C8, K8, KO | keratin 8 |
C00000919
|
8022 | LHX3, CPHD3, LIM3, M2-LHX3 | LIM homeobox 3 |
C00000919
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00001040
|
1588 | CYP19A1, ARO, ARO1, CPV1, CYAR, CYP19, CYPXIX, P-450AROM | cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00001040
|
4153 | MBL2, COLEC1, HSMBPC, MBL, MBL2D, MBP, MBP-C, MBP1, MBPD | mannose-binding lectin (protein C) 2, soluble |
C00000919
|
4170 | MCL1, BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1, TM, bcl2-L-3, mcl1/EAT | myeloid cell leukemia sequence 1 (BCL2-related) |
C00000919
|
4212 | MEIS2, HsT18361, MRG1 | Meis homeobox 2 |
C00000919
|
4222 | MEOX1, KFS2, MOX1 | mesenchyme homeobox 1 |
C00000919
|
4255 | MGMT | O-6-methylguanine-DNA methyltransferase (EC:2.1.1.63) |
C00000919
|
3110 | MNX1, HB9, HLXB9, HOXHB9, SCRA1 | motor neuron and pancreas homeobox 1 |
C00000919
|
4439 | MSH5, G7, MUTSH5, NG23 | mutS homolog 5 |
C00000919
|
4586 | MUC5AC, MUC5, TBM, leB | mucin 5AC, oligomeric mucus/gel-forming |
C00000919
|
4842 | NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS | nitric oxide synthase 1 (neuronal) (EC:1.14.13.39) |
C00000919
|
8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 |
C00000919
|
4973 | OLR1, CLEC8A, LOX1, LOXIN, SCARE1, SLOX1 | oxidized low density lipoprotein (lectin-like) receptor 1 |
C00000919
|
5098 | PCDHGC3, PC43, PCDH-GAMMA-C3, PCDH2 | protocadherin gamma subfamily C, 3 |
C00000919
|
5359 | PLSCR1, MMTRA1B | phospholipid scramblase 1 |
C00000919
|
57048 | PLSCR3 | phospholipid scramblase 3 |
C00000919
|
57088 | PLSCR4, TRA1 | phospholipid scramblase 4 |
C00000919
|
10635 | RAD51AP1, PIR51 | RAD51 associated protein 1 |
C00000919
|
5892 | RAD51D, BROVCA4, R51H3, RAD51L3, TRAD | RAD51 paralog D |
C00000919
|
5914 | RARA, NR1B1, RAR | retinoic acid receptor, alpha |
C00000919
|
5915 | RARB, HAP, NR1B2, RRB2 | retinoic acid receptor, beta |
C00000919
|
5918 | RARRES1, LXNL, TIG1 | retinoic acid receptor responder (tazarotene induced) 1 |
C00000919
|
5950 | RBP4, RDCCAS | retinol binding protein 4, plasma |
C00000919
|
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00001040
|
949 | SCARB1, CD36L1, CLA-1, CLA1, HDLQTL6, SR-BI, SRB1 | scavenger receptor class B, member 1 |
C00000919
|
4990 | SIX6, MCOPCT2, OPTX2, Six9 | SIX homeobox 6 |
C00000919
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00001040
|
9517 | SPTLC2, HSN1C, LCB2, LCB2A, NSAN1C, SPT2, hLCB2a | serine palmitoyltransferase, long chain base subunit 2 (EC:2.3.1.50) |
C00000919
|
6720 | SREBF1, SREBP-1c, SREBP1, bHLHd1 | sterol regulatory element binding transcription factor 1 |
C00000919
|
7052 | TGM2, G-ALPHA-h, GNAH, TG2, TGC | transglutaminase 2 (EC:2.3.2.13) |
C00000919
|
7047 | TGM4, TGP, hTGP | transglutaminase 4 (EC:2.3.2.13) |
C00000919
|
9429 | ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR1, UAQTL1 | ATP-binding cassette, sub-family G (WHITE), member 2 |
C00001040
|
3604 | TNFRSF9, 4-1BB, CD137, CDw137, ILA | tumor necrosis factor receptor superfamily, member 9 |
C00000919
|
8743 | TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL | tumor necrosis factor (ligand) superfamily, member 10 |
C00000919
|
10190 | TXNDC9, APACD, PHLP3 | thioredoxin domain containing 9 |
C00000919
|
7517 | XRCC3, CMM6 | X-ray repair complementing defective repair in Chinese hamster cells 3 |
C00000919
|
335 | APOA1 | apolipoprotein A-I |
C00007366
|
338 | APOB, FLDB, LDLCQ4 | apolipoprotein B |
C00007366
|
351 | APP, AAA, ABETA, ABPP, AD1, APPI, CTFgamma, CVAP, PN-II, PN2 | amyloid beta (A4) precursor protein |
C00007366
|
1386 | ATF2, CRE-BP1, CREB2, HB16, TREB7 | activating transcription factor 2 (EC:2.3.1.48) |
C00007366
|
2101 | ESRRA, ERR1, ERRa, ERRalpha, ESRL1, NR3B1 | estrogen-related receptor alpha |
C00001040
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00007366
|
840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00007366
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00007366
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00007366
|
847 | CAT | catalase (EC:1.11.1.6) |
C00007366
|
1080 | CFTR, ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR, dJ760C5.1 | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) |
C00007366
|
1382 | CRABP2, CRABP-II, RBP6 | cellular retinoic acid binding protein 2 |
C00007366
|
1401 | CRP, PTX1 | C-reactive protein, pentraxin-related |
C00007366
|
1649 | DDIT3, CEBPZ, CHOP, CHOP-10, CHOP10, GADD153 | DNA-damage-inducible transcript 3 |
C00007366
|
83939 | EIF2A, EIF-2A, MST089, MSTP004, MSTP089 | eukaryotic translation initiation factor 2A, 65kDa |
C00007366
|
2335 | FN1, CIG, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF | fibronectin 1 |
C00007366
|
2534 | FYN, SLK, SYN, p59-FYN | FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2) |
C00007366
|
2879 | GPX4, GPx-4, GSHPx-4, MCSP, PHGPx, snGPx, snPHGPx | glutathione peroxidase 4 (EC:1.11.1.12) |
C00007366
|
3048 | HBG2, TNCY | hemoglobin, gamma G |
C00007366
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00007366
|
3240 | HP, BP, HP2ALPHA2, HPA1S | haptoglobin |
C00007366
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00007366
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00007366
|
3932 | LCK, LSK, YT16, p56lck, pp58lck | lymphocyte-specific protein tyrosine kinase (EC:2.7.10.2) |
C00007366
|
4067 | LYN, JTK8, p53Lyn, p56Lyn | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog (EC:2.7.10.2) |
C00007366
|
1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00007366
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00007366
|
5601 | MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK | mitogen-activated protein kinase 9 (EC:2.7.11.24) |
C00007366
|
4155 | MBP | myelin basic protein |
C00007366
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00007366
|
4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00007366
|
11315 | PARK7, DJ-1, DJ1 | parkinson protein 7 |
C00007366
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00007366
|
5230 | PGK1, MIG10, PGKA | phosphoglycerate kinase 1 (EC:2.7.2.3) |
C00007366
|
5340 | PLG | plasminogen (EC:3.4.21.7) |
C00007366
|
5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00007366
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00007366
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00007366
|
6401 | SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2 | selectin E |
C00007366
|
4089 | SMAD4, DPC4, JIP, MADH4, MYHRS | SMAD family member 4 |
C00007366
|
6622 | SNCA, NACP, PARK1, PARK4, PD1 | synuclein, alpha (non A4 component of amyloid precursor) |
C00007366
|
7015 | TERT, CMM9, DKCA2, DKCB4, EST2, PFBMFT1, TCS1, TP2, TRT, hEST2, hTRT | telomerase reverse transcriptase (EC:2.7.7.49) |
C00007366
|
8795 | TNFRSF10B, CD262, DR5, KILLER, KILLER/DR5, TRAIL-R2, TRAILR2, TRICK2, TRICK2A, TRICK2B, TRICKB, ZTNFR9 | tumor necrosis factor receptor superfamily, member 10b |
C00007366
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00007366
|
7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00007366
|
7494 | XBP1, TREB5, XBP-1, XBP2 | X-box binding protein 1 |
C00007366
|
OMIM | preferred title | UniProt |
---|---|---|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 P47869 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#613546 | Aromatase deficiency |
P11511
|
#139300 | Aromatase excess syndrome; aexs |
P11511
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#614490 | Blood group, junior system; jr |
Q9UNQ0
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#604931 | Cortisone reductase deficiency 1; cortrd1 |
P28845
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#607208 | Dravet syndrome |
P18507
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#607681 | Epilepsy, childhood absence, susceptibility to, 2; eca2 |
P18507
|
#612269 | Epilepsy, childhood absence, susceptibility to, 5; eca5 |
P28472
|
#613060 | Epilepsy, idiopathic generalized, susceptibility to, 10; eig10 |
O14764
|
#611136 | Epilepsy, juvenile myoclonic, susceptibility to, 5; ejm5 |
P14867
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#609446 | Generalized epilepsy and paroxysmal dyskinesia; gepd |
Q12791
|
#604233 | Generalized epilepsy with febrile seizures plus, type 1; gefsp1 |
P18507
|
#611277 | Generalized epilepsy with febrile seizures plus, type 3; gefsp3 |
P18507
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
P04626
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#172700 | Pick disease of brain |
P10636
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#605361 | Spinocerebellar ataxia 14; sca14 |
P05129
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601367 | Stroke, ischemic |
P24723
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
#614916 | Ventricular tachycardia, catecholaminergic polymorphic, 4; cpvt4 |
P62158
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00783 | Febrile seizures |
O14764
(related)
P18507 (related) |
H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) Q16790 (marker) |
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
P11511 (related) |
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
P05129
(related)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00794 | Aromatase excess syndrome |
P11511
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00808 | Idiopathic generalized epilepsies (IGEs) |
P14867
(related)
P18507 (related) |
H00003 | Acute myeloid leukemia (AML) |
P15144
(marker)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01111 | Cortisone reductase deficiency (CRD) |
P28845
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00408 | Type I diabetes mellitus |
Q04759
(related)
|
H01258 | Generalized epilepsy and paroxysmal dyskinesia (GEPD) |
Q12791
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D002318 | Cardiovascular Diseases |
C00000919
C00007366 |
D008175 | Lung Neoplasms |
C00000919
C00007366 |
D008113 | Liver Neoplasms |
C00000919
C00007366 |
D056486 | Drug-Induced Liver Injury |
C00000919
C00007366 |
D009422 | Nervous System Diseases |
C00007366
|
D000435 | Alcoholic Intoxication |
C00000919
|
D003930 | Diabetic Retinopathy |
C00000919
|
D002545 | Brain Ischemia |
C00000919
|
D006526 | Hepatitis C |
C00000919
|
D015658 | HIV Infections |
C00000919
|
D006986 | Hypervitaminosis A |
C00000919
|
D008107 | Liver Diseases |
C00000919
|
D053627 | Asthenozoospermia |
C00000919
|
D008114 | Liver Neoplasms, Experimental |
C00000919
|
D001145 | Arrhythmias, Cardiac |
C00000919
|
D009369 | Neoplasms |
C00000919
|
D009845 | Oligospermia |
C00000919
|
D013272 | Stomach Diseases |
C00000919
|
D013276 | Stomach Ulcer |
C00000919
|
D015746 | Abdominal Pain |
C00007366
|
D058186 | Acute Kidney Injury |
C00007366
|
D000755 | Anemia, Sickle Cell |
C00007366
|
D001247 | Asthenia |
C00007366
|
C535393 | Ataxia with vitamin E deficiency |
C00007366
|
D001284 | Atrophy |
C00007366
|
D001836 | Body Weight Changes |
C00007366
|
D001930 | Brain Injuries |
C00007366
|
D002279 | Carcinoma 256, Walker |
C00007366
|
D002471 | Cell Transformation, Neoplastic |
C00007366
|
D002493 | Central Nervous System Diseases |
C00007366
|
D003072 | Cognition Disorders |
C00007366
|
D003556 | Cystitis |
C00007366
|
D003924 | Diabetes Mellitus, Type 2 |
C00007366
|
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00007366
|
D005334 | Fever |
C00007366
|
D005355 | Fibrosis |
C00007366
|
D005767 | Gastrointestinal Diseases |
C00007366
|
D005923 | Glomerulosclerosis, Focal Segmental |
C00007366
|
D006261 | Headache |
C00007366
|
D006461 | Hemolysis |
C00007366
|
D006949 | Hyperlipidemias |
C00007366
|
D006965 | Hyperplasia |
C00007366
|
D006973 | Hypertension |
C00007366
|
D007511 | Ischemia |
C00007366
|
D007674 | Kidney Diseases |
C00007366
|
D008569 | Memory Disorders |
C00007366
|
D009135 | Muscular Diseases |
C00007366
|
D009203 | Myocardial Infarction |
C00007366
|
D009325 | Nausea |
C00007366
|
D009336 | Necrosis |
C00007366
|
D009362 | Neoplasm Metastasis |
C00007366
|
D009410 | Nerve Degeneration |
C00007366
|
D006528 | Carcinoma, Hepatocellular |
C00000919
|
D009436 | Neural Tube Defects |
C00007366
|
D010014 | Osteolysis |
C00007366
|
D010049 | Ovarian Diseases |
C00007366
|
D010146 | Pain |
C00007366
|
D011041 | Poisoning |
C00007366
|
D011230 | Precancerous Conditions |
C00007366
|
D011507 | Proteinuria |
C00007366
|
D011561 | Pseudoxanthoma Elasticum |
C00007366
|
D011657 | Pulmonary Eosinophilia |
C00007366
|
D011832 | Radiation Injuries |
C00007366
|
D051437 | Renal Insufficiency |
C00007366
|
D015427 | Reperfusion Injury |
C00007366
|
D012174 | Retinitis Pigmentosa |
C00007366
|
D012640 | Seizures |
C00007366
|
D014029 | Tobacco Use Disorder |
C00007366
|
D014591 | Uterine Diseases |
C00007366
|
D014717 | Vertigo |
C00007366
|